Anti-EGFR antibody conjugated organic–inorganic hybrid lipid nanovesicles selectively target tumor cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anti-EGFR antibody conjugated organic–inorganic hybrid lipid nanovesicles selectively target tumor cells

Published:2014-09 Issue: Volume:121 Page:141-149
ISSN:0927-7765
Container-title:Colloids and Surfaces B: Biointerfaces
language:en
Short-container-title:Colloids and Surfaces B: Biointerfaces

Author:

Leung Siu Ling,Zha Zhengbao,Cohn Celine,Dai Zhifei,Wu Xiaoyi

Funder

US National Institutes of Health

National Science Foundation

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Colloid and Surface Chemistry,Physical and Theoretical Chemistry,Surfaces and Interfaces,General Medicine,Biotechnology

Reference40 articles.

1. Hand-foot syndrome associated with liposome-encapsulated doxorubicin therapy

2. Liposomes targeted via two different antibodies: Assay, B-cell binding and cytotoxicity

3. Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle

4. Multimodal Nanodiamond Drug Delivery Carriers for Selective Targeting, Imaging, and Enhanced Chemotherapeutic Efficacy

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanohybrid cerasomes: Advancements in targeted drug and gene delivery;European Journal of Medicinal Chemistry Reports;2024-12

2. Bile salt integrated cerasomes: A potential nanocarrier for enhancement of the oral bioavailability of idarubicin hydrochloride;International Journal of Pharmaceutics;2024-09

3. Generation of Novel Tumour-Selective SEA Superantigen-Based Peptides with Improved Safety and Efficacy for Precision Cancer Immunotherapy;International Journal of Molecular Sciences;2024-08-30

4. Novel SPEA Superantigen Peptide Agonists and Peptide Agonist-TGFαL3 Conjugate. In Vitro Study of Their Growth-Inhibitory Effects for Targeted Cancer Immunotherapy;International Journal of Molecular Sciences;2023-06-22

5. Lipid Nanoparticles Functionalized with Antibodies for Anticancer Drug Therapy;Pharmaceutics;2023-01-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3